A-LIST Pulse of the Community, Volume 11, May 2022

The mission of the UsAgainstAlzheimer’s A-LIST® is to use survey results to make life better for the broader Alzheimer’s and dementia community.

Say Hello to BrainGuide

Our platform BrainGuide™ empowers people of all ages and communities to understand and take action on brain health and Alzheimer's disease.

Biden Administration and Congress Take a Major Step to Accelerate Research to Treat and Cure Serious Illnesses

A group of leading scientists and patient advocates today applauded the Biden Administration and Congress for making the Advanced Research Projects Agency for Health (ARPA-H) a reality.

New Survey: Three in Four in Alzheimer’s Community Want Medicare to Cover Alzheimer’s Treatments

A new A-LIST® survey of people with Alzheimer’s and Alzheimer’s caregivers shows that 75 percent want Medicare to cover new therapies—even after they are told that the drugs have a risk of side effects and still require confirmatory trials.

A-LIST Pulse of the Community, Volume 11, May 2022

Say Hello to BrainGuide

UsAgainstAlzheimer’s Applauds U.S. Senate for Passing Federal Funding Bill

Three in Four in Alzheimer’s Community Want Medicare to Cover Alzheimer’s Treatments

UsAgainstAlzheimer's: Working to End Alzheimer's Disease  

The Alzheimer’s pandemic is one of the most significant health and social economic crises of this generation. It is a national and global emergency that has a devastating health, social and economic toll on millions of people living with this disease, their families and caregivers.

UsAgainstAlzheimer’s exists to conquer Alzheimer’s disease. Since our founding in 2010, we have taken on the toughest problems in the fight to end Alzheimer’s. Our work is driven by the urgency to find effective treatments and the prevention steps needed to reach the time where no one is lost to Alzheimer’s.

We bring all of “Us” together to:

In the past decade, progress has been made, with more hope on the horizon now than ever before.

But every day of delay is another day lost to the millions of people affected by this devastating disease. If nothing changes, by 2050, 14 million Americans will be living with Alzheimer’s at an annual cost of more than $1 trillion. The time to act is now.

Recent News and Blog Posts

  • UsAgainstAlzheimer's

    A-LIST Pulse of the Community Vol 11, May 2022

    The mission of the A-LIST is to use survey results to make...
    Read more
  • Summary of Findings: UsAgainstAlzheimer’s A-LIST Survey on Medicare (CMS) Coverage Decision

    Summary of Findings: UsAgainstAlzheimer’s A-LIST Survey on Medicare (CMS) Coverage Decision

     February...

    Read more
  • April 14, 2022

    Alzheimer’s Patient Advocates File FOIA Seeking Answers on Discriminatory Medicare Coverage Decision

    Today, UsAgainstAlzheimer’s announced their latest effort to demand answers from the Centers...

    Read more
  • Virginia Biggar

    Remembering ClergyAgainstAlzheimer’s Founder, Dr. Richard L. Morgan

    The movement to end Alzheimer’s disease has lost a giant. Dr. Richard...

    Read more
  • April 07, 2022

    It’s Official: CMS Denies Medicare Coverage to Alzheimer’s Patients

    “Little difference, a lot of uncertainty” in Coverage Determination

     

    Read more
  • April 01, 2022

    Barragán Leads Colleagues in Call to CMS to Revise Their Non-Coverage Decision for An Entire Class of Alzheimer's Treatments

    Yesterday, Congresswoman Nanette Diaz Barragán led 40 of her colleagues in the...

    Read more

Reports

  • Resources

    A-LIST Pulse of the Community - December 2021

  • Resources

    2020 Annual Report

    In these pages, you will find highlights of the game-changing accomplishments and tremendous progress of UsAgainstAlzheimer's and our partners in the year of 2020. 

  • Resources
    Thumbnail

    Place & Brain Health Equity: Understanding the County-Level Impacts of Alzheimer’s

    The effects of where people live, and the social determinants of health are under-recognized and under-appreciated in our national response to effectively treat and prevent Alzheimer’s. This report found that...